• Profile
Close

Serum CA72-4 is specifically elevated in gout patients and predicts flares

Rheumatology Mar 01, 2020

Bai X, Sun M, He Y, et al. - This study intended to assess serum CA72-4 expression in gout patients and verified the hypothesis that CA72-4 is a predictor of future flares in a prospective gout cohort. A cross-sectional study was performed in individuals with gouty arthritis, asymptomatic hyperuricaemia, four major arthritis types (OA, RA, SpA, septic arthritis) and healthy controls to profile CA72-4 expression. Compared with hyperuricaemia patients, healthy subjects and other arthritis patients, CA72-4 was highly expressed in individuals with gouty arthritis. They observed the gout flares, CA72-4 levels and other gout-related clinical variables at 1, 3 and 6 months during a 6-month follow-up. In gout individuals, CA72-4 levels were upregulated who experienced frequent flares and CA72-4 was a beneficial biomarker to predict future flares.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay